Photo by nci from unsplash
Thrombocytopenia (TCP) is a common finding in cancer patients and traditionally has been considered a relative contraindication to pericardiocentesis (PC). This study analyzed the prognostic factors and overall survival of… Click to show full abstract
Thrombocytopenia (TCP) is a common finding in cancer patients and traditionally has been considered a relative contraindication to pericardiocentesis (PC). This study analyzed the prognostic factors and overall survival of PC in TCP patients with diagnosis of hematologic malignancy. A retrospective
Keywords:
undergoing primary;
pericardiocentesis;
hematological malignancies;
thrombocytopenia undergoing;
overall survival;
malignancies thrombocytopenia
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!